03/19/2026
From: Nixon, Betsy J.
To: [email protected] ; [email protected] ; [email protected] ; [email protected] ; [email protected]
Sent: Monday, March 16, 2026 at 02:46:41 PM PDT
Subject: Dog Aging Project and TRIAD clinical trial
Hello,
I am with the Dog Aging Project, a research collaboration studying canine aging with over 51,000 dogs enrolled in the observational study. I wanted to share some updates for one of the Project's initiatives, the Test of Rapamycin in Aging Dogs (TRIAD), a clinical trial to evaluate the impact of the drug, rapamycin, on healthspan and lifespan in aging dogs.
As of today, TRIAD has 256 dogs enrolled in the clinical trial, with a goal of 580. To date, 47 have completed their three-year participation, providing valuable data for researchers. We are asking if you could help us raise awareness about this important initiative so we can achieve our enrollment goal.
TRIAD has specific eligibility criteria including that a dog must be 7 years or older, weigh between 44 and 120 pounds, be spayed or neutered, and in overall good health. Participants are required to bring their dog to a clinical trial site for an exam seven times over three years. Clinical trial sites are located throughout the U.S. (see map), including sites in San Francisco and Lawndale, CA.
Would you be willing to share information with your members, volunteers, and communities? To make sharing easier, we have downloadable resources, including social media posts, flyers, and templates for newsletter articles, blog, and email blasts. You can also share the Dog Aging Project’s posts from any social media platform.
Let me know if you have questions or would like to talk further. Thanks in advance for supporting this important study!
Betsy
Betsy Nixon | Partnerships and Recruitment| Dog Aging Project
School of Veterinary Medicine & Biomedical Science
Texas A&M University, College Station, TX
[email protected] | Main (979) 845-2844 | Ofc (979) 458-2764
dogagingproject.org
